Clinical trial
Analysis of T-Cell Immune Reconstitution Following Allogeneic Hematopoietic BMT…
NCT00228631 · Emory University, Other · Completed
Key facts
| NCT number | NCT00228631 |
|---|---|
| Title | Analysis of T-Cell Immune Reconstitution Following Allogeneic Hematopoietic BMT for Severe SCD |
| Official title | Analysis of T-Cell Immune Reconstitution Following Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Disease (ImmuneReconstSCD) |
| Lead sponsor | Emory University, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Sickle Cell Disease |
| Enrollment | 7 |
| Start date | Sep 1, 2005 |
| Primary completion | Aug 1, 2011 |
| Completion | Jul 1, 2012 |
| First posted | Sep 29, 2005 |
| Last update posted | May 26, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: